Literature DB >> 12022028

[New finding: transitory horizontal pendular nystagmus secondary to neonatal abstinence syndrome].

Marie-Claire Gaillard1, François-Xavier Borruat.   

Abstract

UNLABELLED: New finding: transient horizontal pendular nystagmus as a sequella to post-natal withdrawal syndrome.
BACKGROUND: Children born of mothers who abused illegal substances during pregnancy can present with signs and symptoms of a withdrawal syndrome, including irritability, jitteriness, diarrhoea. Usually these symptoms appear from a few hours up to a few days after birth. It is frequently followed by a post-withdrawal period of several weeks duration with crying, excitability, sleep irregularities and feeding difficulties. The purpose is to report the presence of nystagmus in infants born from drug-addicted mothers.
METHODS: Five children born from drug-addicted mothers were examined.
RESULTS: Three children (case 1 - 3) presented with congenital horizontal pendular nystagmus. Two other children (case 4 - 5) presented with a peculiar transient horizontal nystagmus, lasting 6 months and 7 months respectively.
CONCLUSIONS: To our knowledge, transient horizontal pendular nystagmus has never been reported in the literature. It was detected in two children who suffered from a post-natal withdrawal syndrome necessitating substitution therapy, including morphine. This may represent a form of morphine midbrain toxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022028     DOI: 10.1055/s-2002-30650

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Nystagmus secondary to drug exposure in utero.

Authors:  Alan O Mulvihill; Peter D Cackett; Nick D George; Brian W Fleck
Journal:  Br J Ophthalmol       Date:  2006-12-13       Impact factor: 4.638

2.  Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis.

Authors:  Victoria J Monnelly; Ruth Hamilton; Francesca M Chappell; Helen Mactier; James P Boardman
Journal:  Dev Med Child Neurol       Date:  2018-12-03       Impact factor: 5.449

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.